524828 Stock Overview
Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
BDH Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹343.95 |
| 52 Week High | ₹407.65 |
| 52 Week Low | ₹174.70 |
| Beta | 0.38 |
| 11 Month Change | 10.52% |
| 3 Month Change | -2.16% |
| 1 Year Change | 84.97% |
| 33 Year Change | 176.82% |
| 5 Year Change | 421.14% |
| Change since IPO | 9,727.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524828 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 11.9% | 0.5% | 0.5% |
| 1Y | 85.0% | 42.5% | 27.5% |
Return vs Industry: 524828 exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 524828 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 524828 volatility | |
|---|---|
| 524828 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524828 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524828's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1935 | 117 | Jayashree Nair | www.bdhind.com |
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products.
BDH Industries Limited Fundamentals Summary
| 524828 fundamental statistics | |
|---|---|
| Market cap | ₹1.98b |
| Earnings (TTM) | ₹97.16m |
| Revenue (TTM) | ₹806.58m |
20.4x
P/E Ratio2.5x
P/S RatioIs 524828 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524828 income statement (TTM) | |
|---|---|
| Revenue | ₹806.58m |
| Cost of Revenue | ₹559.36m |
| Gross Profit | ₹247.21m |
| Other Expenses | ₹150.06m |
| Earnings | ₹97.16m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.88 |
| Gross Margin | 30.65% |
| Net Profit Margin | 12.05% |
| Debt/Equity Ratio | 5.8% |
How did 524828 perform over the long term?
See historical performance and comparison